Publiziert in: Marktpuls, Unternehmen
Frei

Roche Investor Update: Invitation to Roche Analyst Event at ASCO 2016 Mittwoch, 27. April 2016 - 11:09

Roche - Investor Update

Basel, 27 April 2016
Invitation to Roche Analyst Event at ASCO 2016
We are pleased to invite you to an analyst briefing to discuss data presented on the Roche Group's oncology products and pipeline at the American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago (3 - 7 June 2016).
Meeting information
Date: 5 June 2016
Time (CDT):
6:00pm Registration desk opens
6:30pm Start of meeting
8:00pm End of meeting followed by a buffet reception
Download to my calender (download to your calendar will be in local time Chicago)
Venue
Marriott Downtown Chicago
Chicago E-H (Level 5)
540 North Michigan Avenue
60611 Chicago
map
To register for the event, please follow the link (Password: Analyst2016).

Dial in to the conference 10-15 minutes prior to the scheduled start, using the following dial-in numbers (listen-only mode, no live-access to speakers):
+41 (0) 58 310 5000 (Europe and ROW) or
+44 (0) 203 059 5862 (UK) or
+1 (1) 631 570 5613 (USA)

To expedite the registration process on the day of the conference call, you may pre-register for the event. > click here

Alternatively a live audio webcast can be accessed via > http://ir.roche.com.
The presentation slides will be available from the IR website at > http://ir.roche.com following to the closure of the ASCO meeting.
A replay of the webcast will be available on demand on the Roche website. > click here.
 
Best regards,
Karl Mahler
Head of Investor Relations
Sabine Borngräber
Investor Relations Officer
Up
Roche Investor Relations
Dr. Karl Mahler
Phone: +41 61 68-78503
e-mail: karl.mahler@roche.com
Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com
Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: bruno.eschli@roche.com
Dr. Tamer Farhan
Phone: +41 61 68-82552
e-mail: tamer.farhan@roche.com
Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: birgit.masjost@roche.com
 
Investor Relations North America
Nina Goworek
Phone: +1 650 467-8737
e-mail: goworek.nina@gene.com